CA2260756A1 - Systeme pour traiter genetiquement les anomalies de conduction cardiaque - Google Patents
Systeme pour traiter genetiquement les anomalies de conduction cardiaqueInfo
- Publication number
- CA2260756A1 CA2260756A1 CA002260756A CA2260756A CA2260756A1 CA 2260756 A1 CA2260756 A1 CA 2260756A1 CA 002260756 A CA002260756 A CA 002260756A CA 2260756 A CA2260756 A CA 2260756A CA 2260756 A1 CA2260756 A1 CA 2260756A1
- Authority
- CA
- Canada
- Prior art keywords
- conduction
- genetic material
- delivering
- heart
- cases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000011128 cardiac conduction Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000010970 Connexin Human genes 0.000 abstract 2
- 108050001175 Connexin Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002064 heart cell Anatomy 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 238000013507 mapping Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
- A61M5/3291—Shafts with additional lateral openings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68227796A | 1996-07-17 | 1996-07-17 | |
US08/682,277 | 1996-07-17 | ||
PCT/US1997/006103 WO1998002150A1 (fr) | 1996-07-17 | 1997-04-04 | Systeme pour traiter genetiquement les anomalies de conduction cardiaque |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2260756A1 true CA2260756A1 (fr) | 1998-01-22 |
CA2260756C CA2260756C (fr) | 2007-07-10 |
Family
ID=38254967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002260756A Expired - Fee Related CA2260756C (fr) | 1996-07-17 | 1997-04-04 | Systeme pour traiter genetiquement les anomalies de conduction cardiaque |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2260756C (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1740699A1 (fr) * | 2004-04-29 | 2007-01-10 | GOLLOB, MIchael H. | Mutations genetiques specifiques a un tissu de connexine 40 |
-
1997
- 1997-04-04 CA CA002260756A patent/CA2260756C/fr not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1740699A1 (fr) * | 2004-04-29 | 2007-01-10 | GOLLOB, MIchael H. | Mutations genetiques specifiques a un tissu de connexine 40 |
EP1740699A4 (fr) * | 2004-04-29 | 2008-10-15 | Michael H Gollob | Mutations genetiques specifiques a un tissu de connexine 40 |
Also Published As
Publication number | Publication date |
---|---|
CA2260756C (fr) | 2007-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5198423A (en) | Functional polypeptide containing a cell binding domain and a heparin binding domain of fibronectin | |
IL118201A0 (en) | Erythropoietin free of animal proteins processes for production and use thereof | |
EP0861894A4 (fr) | Polypeptide suppresseur et de differenciation | |
Park et al. | Overexpression of HSP25 reduces the level of TNFα‐induced oxidative DNA damage biomarker, 8‐hydroxy‐2′‐deoxyguanosine, in L929 cells | |
CA2097185A1 (fr) | Vecteurs recombinants viraux pour l'expression dans des cellules musculaires | |
EP0921818A4 (fr) | Procedes et compositions therapeutiques et diagnostiques obtenues a partir de proteines jagged/notch et d'acides nucleiques | |
EP1005540A4 (fr) | Proteines ikk-beta, acides nucleiques et procedes | |
FR2738151B1 (fr) | Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers | |
Takahashi-Nakamura et al. | Purification and characterization of an inhibitor of calcium-activated neutral protease from rabbit skeletal muscle | |
CA2253287A1 (fr) | Procede pour produire un polypeptide recombine comprenant l'addition d'un inhibiteur de proteases metal-dependantes ou de chymotrypsines au milieu de culture cellulaire | |
ATE293700T1 (de) | Adenovirus mit glutathion peroxydate gene | |
Riordan et al. | Human angiogenin, an organogenic protein | |
Melloni et al. | Identity in Molecular Structure between" Differentiation Enhancing Factor" of Murine Erithroleukemia Cells and the 30-kDa Heparin-Binding Protein of Developing Rat Brain | |
CA2186423A1 (fr) | Proteine qui induit la production d'interferon gamma par des cellules immunocompetentes | |
CHRISTOMANOU et al. | Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen | |
Miyazono et al. | A platelet factor stimulating the proliferation of vascular endothelial cells: partial purification and characterization | |
WO1995030001A3 (fr) | Nouvelle proteine ligand de p-selectine | |
IL91184A0 (en) | N-2,3-butadienyl tri-and tetraaminoalkane derivatives | |
HU895788D0 (en) | Process for producing peptides and medical products containing them | |
DE69533796D1 (de) | Für die glutamatabhängigen chloridkanäle kodierende dna | |
MX9805300A (es) | Acidos nucleicos que codifican factor-2 inductor de interferon gama. | |
CA2260756A1 (fr) | Systeme pour traiter genetiquement les anomalies de conduction cardiaque | |
Medda et al. | Identity of esterase-22 and egasyn, the protein which complexes with microsomal β-glucuronidase | |
DE69837935D1 (de) | Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden | |
Rehm | Enzymatic deglycosylation of the dendrotoxin‐binding protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |